miércoles, 5 de febrero de 2025

Study of Amgen’s early obesity candidate paused by FDA The company said discussions are underway to reopen the study

https://www.statnews.com/2025/02/04/amgen-early-obesity-candidate-paused-by-fda/

No hay comentarios: